Senti Biosciences, Inc.
SNTI
$2.10
$0.041.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | 5.30% | -1.13% | 2.92% | 6.87% | 18.77% |
| Gross Profit | -5.30% | 0.19% | -6.95% | -16.12% | -30.11% |
| SG&A Expenses | 10.65% | -6.41% | -34.06% | -38.09% | -38.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.08% | -3.58% | -15.23% | -16.52% | -12.47% |
| Operating Income | -7.08% | 3.05% | 13.55% | 13.20% | 8.90% |
| Income Before Tax | 32.86% | 25.82% | 32.91% | 36.71% | 11.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 32.86% | 25.82% | 32.91% | 36.71% | 11.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -100.31% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.89% | -2.40% | 14.98% | 25.71% | -0.49% |
| EBIT | -7.08% | 3.05% | 13.55% | 13.20% | 8.90% |
| EBITDA | -7.97% | 2.27% | 13.98% | 14.43% | 10.77% |
| EPS Basic | 74.30% | 23.90% | 20.18% | 20.40% | 2.40% |
| Normalized Basic EPS | 75.06% | 60.61% | 47.77% | 40.27% | 5.87% |
| EPS Diluted | 74.30% | 23.90% | 20.18% | 20.40% | 2.40% |
| Normalized Diluted EPS | 75.06% | 60.61% | 47.77% | 40.27% | 5.87% |
| Average Basic Shares Outstanding | 268.33% | 151.07% | 33.00% | 3.57% | 2.95% |
| Average Diluted Shares Outstanding | 268.33% | 151.07% | 33.00% | 3.57% | 2.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |